Natco Pharma Limited on Friday announced the share buyback schedule commencing on November 19. Last week, the company board decided to buy back shares for a price of Rs 1,000 per share from the open market by spending a maximum of Rs 2.5 billion.
While announcing the schedule, the company said the buyback of shares to an extent of at least 50 per cent of the amount earmarked for this purpose would be completed within six months from the scheduled buyback date. The price of shares determined for buyback comes at a premium of little over 40 per cent of the closing price of company shares on October 26, 2018.
The company has proposed to buy a minimum number of 1.25 million shares from the open market route in the six-month period.
The promoters and promoter group hold 48.25 per cent shares in the company, while 24.31 per cent equity shares are held by foreign institutional investors under the public shareholding classification.
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
-
Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
-
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in